Αποτελέσματα αναζήτησης - Jueliger, Simone
- Εμφανίζονται 1 - 7 Αποτελέσματα από 7
-
1
Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma από Ferrari, Nicola, Ward, George, Gewinner, Christina, Davis, Matthew P., Jueliger, Simone, Saini, Harpreet, Munck, Joanne, Smyth, Tomoko, Ferraldeschi, Roberta, Keer, Harold, Lyons, John, Sims, Martin J.
Έκδοση 2021Κείμενο -
2
Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma από Jueliger, Simone, Lyons, John, Cannito, Sara, Pata, Illar, Pata, Pille, Shkolnaya, Marianna, Lo Re, Oriana, Peyrou, Marion, Villarroya, Francesc, Pazienza, Valerio, Rappa, Francesca, Cappello, Francesco, Azab, Mohammad, Taverna, Pietro, Vinciguerra, Manlio
Έκδοση 2016Κείμενο -
3
A Phase 1 Clinical Trial of Guadecitabine and Carboplatin In Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic And Pharmacodynamic Analyses από Matei, Daniela, Ghamande, Sharad, Roman, Lynda, Secord, Angeles Alvarez, Nemunaitis, John, Markham, Merry Jennifer, Nephew, Kenneth P., Jueliger, Simone, Oganesian, Aram, Naim, Sue, Su, Xiang Yao, Keer, Harold, Azab, Mohammad, Fleming, Gini F
Έκδοση 2018Κείμενο -
4
Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing από Riccadonna, Cristina, Yacoub Maroun, Céline, Vuillefroy de Silly, Romain, Boehler, Margaux, Calvo Tardón, Marta, Jueliger, Simone, Taverna, Pietro, Barba, Leticia, Marinari, Eliana, Pellegatta, Serena, Bassoy, Esen Yonca, Martinvalet, Denis, Dietrich, Pierre-Yves, Walker, Paul R.
Έκδοση 2016Κείμενο -
5
First-in-human study of AT13148, a dual ROCK-AKT inhibitor in patients with solid tumors από McLeod, Robert, Kumar, Rajiv, Papadatos-Pastos, Dionysis, Mateo, Joaquin, Brown, Jessica S, Garces, Alvaro H Ingles, Ruddle, Ruth, Decordova, Shaun, Jueliger, Simone, Ferraldeschi, Roberta, Maiques, Oscar, Sanz-Moreno, Victoria, Jones, Paul, Traub, Stephanie, Halbert, Gavin, Mellor, Sarah, Swales, Karen E, Raynaud, Florence I, Garrett, Michelle D, Banerji, Udai
Έκδοση 2020Κείμενο -
6
A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure από Sébert, Marie, Renneville, Aline, Bally, Cécile, Peterlin, Pierre, Beyne-Rauzy, Odile, Legros, Laurence, Gourin, Marie-Pierre, Sanhes, Laurence, Wattel, Eric, Gyan, Emmanuel, Park, Sophie, Stamatoullas, Aspasia, Banos, Anne, Laribi, Kamel, Jueliger, Simone, Bevan, Luke, Chermat, Fatiha, Sapena, Rosa, Nibourel, Olivier, Chaffaut, Cendrine, Chevret, Sylvie, Preudhomme, Claude, Adès, Lionel, Fenaux, Pierre
Έκδοση 2019Κείμενο -
7
A randomized phase 2 trial of epigenetic priming with guadecitabine and carboplatin in platinum-resistant, recurrent ovarian cancer από Oza, Amit, Matulonis, Ursula, Alvarez Secord, Angeles, Roman, Lynda, Blagden, Sarah, Banerjee, Susana, Nemunaitis, John, McGuire, William, Ghamande, Sharad, Birrer, Michael, Fleming, Gini F, Jennifer Markham, Merry, Hirte, Hal, Provencher, Diane, Basu, Bristi, Kristeleit, Rebecca, Armstrong, Deborah, Schwartz, Benjamin, Braly, Patricia, Hall, Geoffrey, Nephew, Kenneth P., Jueliger, Simone, Oganesian, Aram, Naim, Sue, Hao, Yong, Keer, Harold, Azab, Mohammad, Matei, Daniela
Έκδοση 2019Κείμενο